Artist Adam Green has created the Lives & Times screen print to raise funds for Beating Bowel Cancer. The print sized 39cm x 49cm on 300gsm Somerset paper is limited to just 25 copies. This wonderful piece of art was done at Ochre Print Studio, who have very kindly donated all the materials Adam used ensuring that the whole of the purchase price is donated to the charity.
The print is on sale in the web store on my bowelcancerfundraising.co.uk website or you can email me directly. Get your own piece of art for just £125 and raise funds for Beating Bowel Cancer. Selling just one more print will take the fundraising past £4000.
Adam's description, "The print I have produced has been inspired by Tim's book, Lives & Times. A book created to raise funds for Beating Bowel Cancer after Tim's Mum was diagnosed in 2012. I was really taken with the concept of what Tim was doing with his book, travelling the length and breadth of the UK to meet and photograph famous sportspeople, musicians, actors, DJs etc. The front cover of the book shows two silhouettes facing each other. I took this idea and developed my print with this in mind, thinking about the one to one interaction Tim had with many people in order to create his book. The print is made up of many different layers, each one possibly signifying the different stages in the journey that people follow once being diagnosed with cancer. I am very pleased to have produced this print for Tim and his charity. I really hope it brings joy and positive thoughts to all those who purchase one."
I was so glad to show Mum the finished print when she was Wexham Park Hospital shortly before she was transferred to the St. Marks Nursing Home in Maidenhead, where she passed away in August 2016.
Bowel cancer takes 16,000 lives in the UK each year. It is the second highest cancer killer, but if detected early at stage 1 it is one of the most treatable in around 97% of cases with patients living for 5 years or more. This figure falls to just 7% when detected at the later stage 4. At the moment only 15% of cases are diagnosed at stage 1.
